RecruitingNCT04822142

Congenital CYtoMEgalovirus Infection in VIEtnam (CYMEVIE)

Congenital Cytomegalovirus Infection in Vietnam: Prevalence, Morbidity and Risk Factors


Sponsor

Hanoi Obstetrics and Gynecology Hospital

Enrollment

5,000 participants

Start Date

Apr 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

To estimate the prevalence of congenital CMV infection in Vietnamese neonates and relating morbidity within 2-year follow-up. Along with evaluating the predictive value of the presence and the level of CMV replication in the first trimester in a highly seropositive population


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Vietnamese pregnant women in the first trimester of pregnancy and at delivery and subsequent live neonates at birth.
  • Informed consent

Exclusion Criteria6

  • Women under 18 years old.
  • Miscarriages
  • Stillbirths
  • Premature delivery before 34th gestational week
  • Loss to follow-up maternal monitoring.
  • Participation in another interventional study that influences management of labour at delivery or perinatal morbidity or mortality.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Hanoi Obstetrics and Gynecology Hospital

Hanoi, Vietnam

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04822142


Related Trials